SynAct Pharma AB (STO:SYNACT)
Sweden · Delayed Price · Currency is SEK 22.60
-0.45 (-1.95%)
Dec 30, 2025, 5:29 PM CET
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 1.21 billion as of December 31, 2025. Its market cap has increased by 194.21% in one year.
Market Cap
1.21B
Enterprise Value
1.13B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
22.60
Market Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 1.21B, an increase of 1,790.55%. That is a compound annual growth rate of 36.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 1.21B | 189.20% |
| Dec 30, 2024 | 416.76M | 32.69% |
| Dec 29, 2023 | 314.09M | -87.00% |
| Dec 30, 2022 | 2.42B | -34.75% |
| Dec 30, 2021 | 3.70B | 242.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 11, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.70B |
| Getinge AB | 59.59B |
| Sectra AB | 48.36B |
| Camurus AB | 36.74B |
| Medicover AB | 33.29B |
| Asker Healthcare Group AB | 32.33B |
| BioArctic AB | 27.78B |
| Elekta AB | 21.68B |